Advisory Resource Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36,128
Closed -$2.68M 152
2023
Q1
$2.68M Buy
36,128
+8,145
+29% +$683K 0.75% 38
2022
Q4
$2.61M Buy
27,983
+1,637
+6% +$158K 0.78% 35
2022
Q3
$2.51M Buy
26,346
+334
+1% +$33.1K 0.83% 24
2022
Q2
$2.41M Buy
26,012
+1,574
+6% +$154K 0.79% 32
2022
Q1
$2.47M Sell
24,438
-1,632
-6% -$171K 0.77% 36
2021
Q4
$2.78M Sell
26,070
-14
-0.1% -$1.29K 0.93% 24
2021
Q3
$2.21M Buy
26,084
+553
+2% +$46.3K 0.82% 33
2021
Q2
$2.13M Buy
25,531
+1,715
+7% +$140K 0.85% 34
2021
Q1
$1.79M Buy
23,816
+82
+0.3% +$5.97K 0.84% 34
2020
Q4
$1.62M Buy
23,734
+206
+0.9% +$13.4K 0.8% 35
2020
Q3
$1.37M Buy
+23,528
New +$1.46M 0.81% 34

Other funds holding CVS

Advisory Resource Group's CVS Position: Q2 2023 in Review

Advisory Resource Group sold out of CVS Health (CVS) in Q2 2023, closing a stake of 36,128 shares — an estimated $2.68M sold.

Advisory Resource Group first reported a position in CVS in Q3 2020 and held it in 11 quarters. The position peaked at $2.78M in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Advisory Resource Group reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Advisory Resource Group sold 36,128 CVS Health shares in Q2 2023, an estimated $2.68M.
  • Advisory Resource Group first reported a position in CVS Health in Q3 2020 and held it in 11 quarters.
  • Advisory Resource Group's CVS Health position peaked at $2.78M in Q4 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Advisory Resource Group's 13F filing for Q2 2023, filed 11 Jul 2023.